|
Synonyms: Spedra® | Stendra® | TA-1790
avanafil is an approved drug (FDA (2012), EMA (2013))
Compound class:
Synthetic organic
Comment: Avanafil is a phosphodiesterase type 5 inhibitor.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Most of the research into the pharmacology of this drug appears to have been carried out in dogs. We have been unable to find publicly available bioactivity for avanafil in relation to human PDE5 to substantiate its clinical MMOA. Therefore, we have not tagged a primary target for this drug. |